39
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      British Society of Gastroenterology/Association of Coloproctology of Great Britain and Ireland/Public Health England post-polypectomy and post-colorectal cancer resection surveillance guidelines

      research-article

      Read this article at

      ScienceOpenPublisherPMC
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          These consensus guidelines were jointly commissioned by the British Society of Gastroenterology (BSG), the Association of Coloproctology of Great Britain and Ireland (ACPGBI) and Public Health England (PHE). They provide an evidence-based framework for the use of surveillance colonoscopy and non-colonoscopic colorectal imaging in people aged 18 years and over. They are the first guidelines that take into account the introduction of national bowel cancer screening. For the first time, they also incorporate surveillance of patients following resection of either adenomatous or serrated polyps and also post-colorectal cancer resection. They are primarily aimed at healthcare professionals, and aim to address:

          1. Which patients should commence surveillance post-polypectomy and post-cancer resection?

          2. What is the appropriate surveillance interval?

          3. When can surveillance be stopped?

          • two or more premalignant polyps including at least one advanced colorectal polyp (defined as a serrated polyp of at least 10 mm in size or containing any grade of dysplasia, or an adenoma of at least 10 mm in size or containing high-grade dysplasia); or

          • five or more premalignant polyps

          The Appraisal of Guidelines for Research and Evaluation (AGREE II) instrument provided a methodological framework for the guidelines. The BSG’s guideline development process was used, which is National Institute for Health and Care Excellence (NICE) compliant.

          • two or more premalignant polyps including at least one advanced colorectal polyp (defined as a serrated polyp of at least 10 mm in size or containing any grade of dysplasia, or an adenoma of at least 10 mm in size or containing high-grade dysplasia); or

          • five or more premalignant polyps

          The key recommendations are that the high-risk criteria for future colorectal cancer (CRC) following polypectomy comprise either:

          • two or more premalignant polyps including at least one advanced colorectal polyp (defined as a serrated polyp of at least 10 mm in size or containing any grade of dysplasia, or an adenoma of at least 10 mm in size or containing high-grade dysplasia); or

          • five or more premalignant polyps

          This cohort should undergo a one-off surveillance colonoscopy at 3 years. Post-CRC resection patients should undergo a 1 year clearance colonoscopy, then a surveillance colonoscopy after 3 more years.

          Related collections

          Most cited references164

          • Record: found
          • Abstract: not found
          • Article: not found

          AGREE II: advancing guideline development, reporting and evaluation in health care.

            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Colorectal cancer screening for average-risk adults: 2018 guideline update from the American Cancer Society

            In the United States, colorectal cancer (CRC) is the fourth most common cancer diagnosed among adults and the second leading cause of death from cancer. For this guideline update, the American Cancer Society (ACS) used an existing systematic evidence review of the CRC screening literature and microsimulation modeling analyses, including a new evaluation of the age to begin screening by race and sex and additional modeling that incorporates changes in US CRC incidence. Screening with any one of multiple options is associated with a significant reduction in CRC incidence through the detection and removal of adenomatous polyps and other precancerous lesions and with a reduction in mortality through incidence reduction and early detection of CRC. Results from modeling analyses identified efficient and model-recommendable strategies that started screening at age 45 years. The ACS Guideline Development Group applied the Grades of Recommendations, Assessment, Development, and Evaluation (GRADE) criteria in developing and rating the recommendations. The ACS recommends that adults aged 45 years and older with an average risk of CRC undergo regular screening with either a high-sensitivity stool-based test or a structural (visual) examination, depending on patient preference and test availability. As a part of the screening process, all positive results on noncolonoscopy screening tests should be followed up with timely colonoscopy. The recommendation to begin screening at age 45 years is a qualified recommendation. The recommendation for regular screening in adults aged 50 years and older is a strong recommendation. The ACS recommends (qualified recommendations) that: 1) average-risk adults in good health with a life expectancy of more than 10 years continue CRC screening through the age of 75 years; 2) clinicians individualize CRC screening decisions for individuals aged 76 through 85 years based on patient preferences, life expectancy, health status, and prior screening history; and 3) clinicians discourage individuals older than 85 years from continuing CRC screening. The options for CRC screening are: fecal immunochemical test annually; high-sensitivity, guaiac-based fecal occult blood test annually; multitarget stool DNA test every 3 years; colonoscopy every 10 years; computed tomography colonography every 5 years; and flexible sigmoidoscopy every 5 years. CA Cancer J Clin 2018;68:250-281. © 2018 American Cancer Society.
              Bookmark
              • Record: found
              • Abstract: not found
              • Article: not found

              A genetic model for colorectal tumorigenesis

                Bookmark

                Author and article information

                Journal
                Gut
                Gut
                gutjnl
                gut
                Gut
                BMJ Publishing Group (BMA House, Tavistock Square, London, WC1H 9JR )
                0017-5749
                1468-3288
                February 2020
                27 November 2019
                : 69
                : 2
                : 201-223
                Affiliations
                [1 ] departmentGastroenterology , University Hospital of North Tees , Stockton-on-Tees, UK
                [2 ] departmentNorthern Institute for Cancer Research , Newcastle University , Newcastle upon Tyne, UK
                [3 ] departmentTranslational Gastroenterology Unit , John Radcliffe Hospital , Oxford, UK
                [4 ] departmentGastroenterology , South Tyneside NHS Foundation Trust , South Shields, UK
                [5 ] Western Sussex Hospitals NHS Foundation Trust , Chichester, UK
                [6 ] departmentColorectal surgery , Raigmore Hospital , Inverness, UK
                [7 ] departmentGastroenterology , Cardiff and Vale NHS Trust , Cardiff, UK
                [8 ] departmentHistopathology , Nottingham University Hospitals , Nottingham, UK
                [9 ] departmentFamily History of Bowel Cancer Clinic , West Middlesex University Hospital , London, UK
                [10 ] Imperial College , London, UK
                [11 ] departmentHistopathology , University College London , London, UK
                [12 ] departmentCentre for Medical Imaging , UCL , London, UK
                [13 ] departmentEndoscopy , St Marks Hospital , London, UK
                [14 ] departmentWolfson Unit for Endoscopy , St Mark’s Hospital , London, UK
                [15 ] departmentClinical Radiology , Leeds Teaching Hospitals NHS Trust , Leeds, UK
                [16 ] departmentSchool of Health and Related Research (ScHARR) , University of Sheffield , Sheffield, UK
                [17 ] departmentGastroenterology , University Hospital of Hartlepool , Hartlepool, UK
                [18 ] London, UK
                [19 ] departmentCancer Screening , Public Health England , London, UK
                [20 ] departmentDepartment of Epidemiology and Biostatistics, School of Public Health, Faculty of Medicine of Imperial College , Imperial College London , London, UK
                [21 ] departmentInstitute of Health and Society , Newcastle University , Newcastle upon Tyne, UK
                Author notes
                [Correspondence to ] Professor Matthew D Rutter, Gastroenterology, University Hospital of North Tees, Stockton-on-Tees TS19 8PE, UK; matt.rutter@ 123456nth.nhs.uk

                AC and LS are joint senior authors.

                Author information
                http://orcid.org/0000-0001-9507-0295
                http://orcid.org/0000-0002-7918-4003
                Article
                gutjnl-2019-319858
                10.1136/gutjnl-2019-319858
                6984062
                31776230
                62b81e75-21b7-4c18-b071-b643053c2031
                © Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

                This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.

                History
                : 17 September 2019
                : 14 October 2019
                : 15 October 2019
                Funding
                Funded by: British Society of Gastroenterology;
                Funded by: FundRef http://dx.doi.org/10.13039/501100002141, Public Health England;
                Categories
                Guidelines
                1506
                2312
                Custom metadata
                unlocked

                Gastroenterology & Hepatology
                colorectal cancer,surveillance,colonoscopy,colonic polyps,colorectal adenomas

                Comments

                Comment on this article